Organon & Co. — Director's Dealing 2024

May 7, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2024-05-04

Reporting Person: Ali Kevin (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-04	Common Stock	M	22161	—	Acquired	147504	Direct
2024-05-04	Common Stock	F	12256	$19.61	Disposed	135248	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-04	Restricted Stock Units	$	M	22161	Disposed		Common Stock (22161)	Direct

Footnotes

F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.

F2: On each of May 4, 2022, May 4, 2023 and May 4, 2024, one-third of the RSUs vested.